EJF Capital’s Exact Sciences EXAS Stock Holding History

EJF Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-30,000	Closed	-$425K	–	140
2014 Q1	$425K	Buy	+30,000	New	+$405K	0.03%	126

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EJF Capital's EXAS Position: Q2 2014 in Review

EJF Capital sold out of Exact Sciences (EXAS) in Q2 2014, closing a stake of 30,000 shares — an estimated $425K sold.

EJF Capital first reported a position in EXAS in Q1 2014 and held it in 1 quarter. The position peaked at $425K in Q1 2014. 156 funds tracked by Wall St. Rank hold EXAS as of Q2 2014.

EJF Capital reported no remaining Exact Sciences position as of Q2 2014 after selling out during the quarter.
EJF Capital sold 30,000 Exact Sciences shares in Q2 2014, an estimated $425K.
EJF Capital first reported a position in Exact Sciences in Q1 2014 and held it in 1 quarter.
EJF Capital's Exact Sciences position peaked at $425K in Q1 2014.
156 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2014.

Based on EJF Capital's 13F filing for Q2 2014, filed 12 Aug 2014.